A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
Clinical trial NCT01277146 · COMPLETED
Trial details
- NCT number
- NCT01277146
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-03-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.